Dr. Iglesia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2019 - 2024- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2017 - 2019
University of North Carolina at Chapel Hill School of MedicineClass of 2017
Certifications & Licensure
MO State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsDifferential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.Michael D Iglesia, Reyka G Jayasinghe, Siqi Chen, Nadezhda V Terekhanova, John M Herndon
Nature Cancer. 2024-11-01 - 4 citationsTherapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms.Rachel P Riechelmann, Rodrigo G Taboada, Victor Hugo F de Jesus, Michael Iglesia, Nikolaos A Trikalinos
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023-05-01 - 3 citationsA phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, Ellis Levine, Jingqin Luo
NPJ Breast Cancer. 2023-01-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
